‘The Paper’s Title Tells You It Shouldn’t be Published’: What We Heard This Week

“The paper’s title tells you that it shouldn’t be published.” — Paul Offit, MD, director of the Vaccine Education Center at Children’s Hospital of Philadelphia, on a study that purportedly suggested an increase in sudden infant death syndrome a few days after vaccination before the journal removed it.

“All the stages of grief — shock, bewilderment, disappointment, anger.” — Ronak Shah, MD, of Emergency Medicine of Blue Ridge in Winchester, Virginia, discussing an emergency medicine group’s reactions to being terminated and replaced by doctors provided by a private equity firm.

“You think about where we were 20 years ago — 25 years ago we had nothing, and now we are on the verge of potential curing the disease.” — Jonathan Bernstein, MD, of the University of Cincinnati, discussing phase III results of the gene therapy lonvoguran ziclumeran (lonvo-z) for hereditary angioedema.

“Your strength is your foundation and it helps build injury resiliency.” — Brian DeVeaux, DPT, of Northwell Sports Therapy and Rehabilitation Services and Hofstra University in Hempstead, New York, on why older soccer stars can still make it to the FIFA World Cup.

“Children who start puberty much earlier than usual should be carefully evaluated so they receive the right care at the right time — without unnecessary tests or treatment.” — Stephanie Roberts, MD, of Boston Children’s Hospital, discussing new recommendations for kids with central precocious puberty.

“We don’t know with certainty why the risk of dementia is lower with shingles vaccination, but we have a lot of ideas.” — Kaleen Hayes, PharmD, PhD, of the Brown University School of Public Health in Providence, Rhode Island, on a study linking herpes zoster vaccines with lower dementia risk among skilled-nursing facility patients.